pepgen, inc. unlocking the potential of exon skipping therapeutics
Published 3 years ago • 937 plays • Length 36:30Download video MP4
Download video MP3
Similar videos
-
40:33
avidity: a new approach to exon skipping
-
1:28
prosensa's video animation on exon skipping
-
1:24:53
2024 futures exon skipping
-
1:26:44
2022 futures exon skipping and read through agents panel
-
1:40:54
restoring dystrophin via exon skipping strategies -- ppmd 2022 annual conference
-
1:52
kevin flanigan talks exon skipping
-
1:04:24
webinar: viltepso - a treatment option for patients amenable to exon 53 skipping (april 2021)
-
47:59
in the pipeline: next-gen exon skipping (ppmd's 2021 virtual annual conference)
-
3:51
exon skipping for duchenne muscular dystrophy explained with a dance!
-
39:33
webinar: ns pharma - overview of new exon skipping trials: brogidirsen and ns-050/ncnp-03 (mar 2024)
-
15:36
can antisense oligonucleotides really cure genetic disorders?
-
3:13
hanugen therapeutics on exon skipping or the tech it uses to treat duchenne muscular dystrophy (dmd)
-
0:26
exon skipping motion graphic
-
37:27
webinar: viltepso, an fda-approved treatment for patients amenable to exon 53 skipping (march 2023)
-
6:03
advancing care with exon skipping therapies for duchenne muscular dystrophy
-
3:51
new exon skipping drug in clinical development for duchenne muscular dystrophy
-
21:46
in the pipeline: gene therapy - audentes therapeutics
-
2:54
genes, exons, and the pathophysiology of dmd (duchenne muscular dystrophy)
-
1:00:58
the basics of genetic approaches for nmds – using dmd as a paradigm - annemieke aartsma-rus
-
36:30
oligonucleotide opportunities in dmd with pepgen's james mcarthur, ph.d.
-
30:47
pepgen's svp head of clinical development on delivery of oligonucleotide therapies
-
1:29
company spotlight - pepgen